The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

September 1, 2014 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Preparing Immunocompromised Patients for Risks of Traveling Abroad
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
  • Immunizations in Immunocomprised Patients
Explore This Issue
September 2014
Also By This Author
  • Is It Time to Replace the HAQ?

Specialists share equal responsibility with primary care providers for ensuring that immunocompromised patients are vaccinated, according to the recent guidelines issued by the Infectious Diseases Society of America.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host states that specialists are in a “pivotal position to ensure vaccination by administering vaccines or providing specific advice to patients and primary care providers.1 Specialists should educate patients and members of their household on the importance of vaccination of household members for the protection of the immunocompromised patient.”

Leonard Calabrese, DO, professor of medicine in the department of rheumatic and immunologic diseases at Cleveland Clinic Lerner College of Medicine, said that immunocompromised patients often are not vaccinated. “There is a gaping hole in immunizations being administered,” he said. Some rheumatologists think immunizations lie outside the scope of their practice, given that vaccines can be expensive or difficult to store. “We do not have a systematic approach to vaccines in our profession that allows for optimal vaccine administration,” Dr. Calabrese said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Gil Melmed, MD, MS, director of clinical inflammatory bowel disease at Cedars-Sinai Medical Center in Los Angeles, agreed. “Specialists are the ones that call the shots for the therapies that suppress the immune system, but often we, as specialist communities, may deflect the responsibility for vaccinations to primary care providers. We have learned from study after study from around the world that patients in specialty care clinics don’t get the vaccinations that they should be getting.”

There are numerous reasons why primary care physicians may not be vaccinating patients who are being treated with immunosuppressive therapy. Some are unfamiliar with newer therapies, such as biologics, and others think that vaccines are unsafe or ineffective for patients who are immunocompromised. Patients on immunosuppressive therapy, however, have a lot to gain with appropriate vaccination. These patients are predisposed to an increased risk or severity of vaccine-preventable infection, and they may have greater exposure to pathogens because of their more frequent contact with medical facilities, the IDSA document states.

Although the response rates to certain vaccines may be somewhat blunted when patients are on immunosuppressive therapies, particularly such immunomodulators as methotrexate or other DMARDs, that should not be used as an excuse to skip vaccinations, Dr. Melmed said. “These patients absolutely should be vaccinated according to recommended guidelines, [because] some protection is better than none.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Additionally, concerns that a vaccine may trigger a disease flare in patients with chronic inflammatory diseases seem unfounded. According to the IDSA guidelines, there is a preponderance of clinical evidence that vaccines are not important disease flare triggers and should not be withheld for that reason.

Pages: 1 2 3 4 | Single Page

Filed Under: Biologics & Biosimilars, Conditions, DMARDs & Immunosuppressives, Drug Updates, Guidelines, Safety Tagged With: AC&R, American College of Rheumatology, Biologics, drug, Guidelines, Holliman, immunocompromised, Methotrexate, patient care, rheumatologist, Safety, vaccinationIssue: September 2014

You Might Also Like:
  • Preparing Immunocompromised Patients for Risks of Traveling Abroad
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
  • Immunizations in Immunocomprised Patients
  • The Latest on Vaccinations, Leprosy & Lyme Disease

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.